FDA black box warning on the use of 80 mg simvastatin: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
Simvastatin 80 mg is the highest approved dose for this drug and it is estimated that approximately 2.1 million patients in the U.S. were prescribes this dose in the year 2010<ref>http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm<ref>. Based on the review of randomized clinical trial, '''Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)''', FDA recommended limiting the use of high-dose simvastatin.
Simvastatin 80 mg is the highest approved dose for this drug and it is estimated that approximately 2.1 million patients in the U.S. were prescribes this dose in the year 2010<ref>http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm<ref>.  
 
 




Revision as of 20:32, 14 September 2011

Template:Hypercholesterolemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Kashish Goel, M.D.


Overview

Simvastatin 80 mg is the highest approved dose for this drug and it is estimated that approximately 2.1 million patients in the U.S. were prescribes this dose in the year 2010<ref>http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm<ref>.


References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=FDA_black_box_warning_on_the_use_of_80_mg_simvastatin&oldid=599767"